265 related articles for article (PubMed ID: 33771701)
1. Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance.
Mirzaei S; Mohammadi AT; Gholami MH; Hashemi F; Zarrabi A; Zabolian A; Hushmandi K; Makvandi P; Samec M; Liskova A; Kubatka P; Nabavi N; Aref AR; Ashrafizadeh M; Khan H; Najafi M
Pharmacol Res; 2021 May; 167():105575. PubMed ID: 33771701
[TBL] [Abstract][Full Text] [Related]
2. The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer.
Hayden A; Douglas J; Sommerlad M; Andrews L; Gould K; Hussain S; Thomas GJ; Packham G; Crabb SJ
Urol Oncol; 2014 Aug; 32(6):806-14. PubMed ID: 24837013
[TBL] [Abstract][Full Text] [Related]
3. Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies.
Mirzaei S; Hushmandi K; Zabolian A; Saleki H; Torabi SMR; Ranjbar A; SeyedSaleh S; Sharifzadeh SO; Khan H; Ashrafizadeh M; Zarrabi A; Ahn KS
Molecules; 2021 Apr; 26(8):. PubMed ID: 33921908
[TBL] [Abstract][Full Text] [Related]
4. Emerging role of NRF2 in ROS-mediated tumor chemoresistance.
Xue D; Zhou X; Qiu J
Biomed Pharmacother; 2020 Nov; 131():110676. PubMed ID: 32858502
[TBL] [Abstract][Full Text] [Related]
5. 4-methoxychalcone enhances cisplatin-induced oxidative stress and cytotoxicity by inhibiting the Nrf2/ARE-mediated defense mechanism in A549 lung cancer cells.
Lim J; Lee SH; Cho S; Lee IS; Kang BY; Choi HJ
Mol Cells; 2013 Oct; 36(4):340-6. PubMed ID: 24046186
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
[TBL] [Abstract][Full Text] [Related]
7. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling.
Fu D; Wang C; Yu L; Yu R
Cell Mol Biol Lett; 2021 Jun; 26(1):26. PubMed ID: 34098867
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia.
Syu JP; Chi JT; Kung HN
Oncotarget; 2016 Mar; 7(12):14659-72. PubMed ID: 26894974
[TBL] [Abstract][Full Text] [Related]
9. Nrf2 activation protects auditory hair cells from cisplatin-induced ototoxicity independent on mitochondrial ROS production.
Zhang W; Xiong H; Pang J; Su Z; Lai L; Lin H; Jian B; He W; Yang H; Zheng Y
Toxicol Lett; 2020 Oct; 331():1-10. PubMed ID: 32428544
[TBL] [Abstract][Full Text] [Related]
10. MDA-7/IL-24 inhibits Nrf2-mediated antioxidant response through activation of p38 pathway and inhibition of ERK pathway involved in cancer cell apoptosis.
Tian H; Zhang D; Gao Z; Li H; Zhang B; Zhang Q; Li L; Cheng Q; Pei D; Zheng J
Cancer Gene Ther; 2014 Oct; 21(10):416-26. PubMed ID: 25236495
[TBL] [Abstract][Full Text] [Related]
11. Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery.
Mirzaei S; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Azami N; Hamzehlou S; Farahani MV; Hushmandi K; Ashrafizadeh M; Khan H; Kumar AP
Antioxidants (Basel); 2021 Feb; 10(3):. PubMed ID: 33652780
[TBL] [Abstract][Full Text] [Related]
12. Natural and synthetic compounds in Ovarian Cancer: A focus on NRF2/KEAP1 pathway.
Tossetta G; Marzioni D
Pharmacol Res; 2022 Sep; 183():106365. PubMed ID: 35901941
[TBL] [Abstract][Full Text] [Related]
13. Osthole promotes the suppressive effects of cisplatin on NRF2 expression to prevent drug-resistant cervical cancer progression.
Su J; Zhang F; Li X; Liu Z
Biochem Biophys Res Commun; 2019 Jun; 514(2):510-517. PubMed ID: 31056260
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells.
Panieri E; Saso L
Antioxid Redox Signal; 2021 Jun; 34(18):1428-1483. PubMed ID: 33403898
[No Abstract] [Full Text] [Related]
15. MicroRNA-140-5p attenuated oxidative stress in Cisplatin induced acute kidney injury by activating Nrf2/ARE pathway through a Keap1-independent mechanism.
Liao W; Fu Z; Zou Y; Wen D; Ma H; Zhou F; Chen Y; Zhang M; Zhang W
Exp Cell Res; 2017 Nov; 360(2):292-302. PubMed ID: 28928081
[TBL] [Abstract][Full Text] [Related]
16. Hesperidin activates Nrf2 to protect cochlear hair cells from cisplatin-induced damage.
Lou J; Wu F; He W; Hu R; Cai Z; Chen G; Zhao W; Zhang Z; Si Y
Redox Rep; 2024 Dec; 29(1):2341470. PubMed ID: 38629504
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer.
Ciamporcero E; Daga M; Pizzimenti S; Roetto A; Dianzani C; Compagnone A; Palmieri A; Ullio C; Cangemi L; Pili R; Barrera G
Free Radic Biol Med; 2018 Feb; 115():447-457. PubMed ID: 29248722
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats.
Sahin K; Tuzcu M; Gencoglu H; Dogukan A; Timurkan M; Sahin N; Aslan A; Kucuk O
Life Sci; 2010 Aug; 87(7-8):240-5. PubMed ID: 20619277
[TBL] [Abstract][Full Text] [Related]
19. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
20. Role of NRF2 in Ovarian Cancer.
Tossetta G; Fantone S; Montanari E; Marzioni D; Goteri G
Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
